Advertisement

Topics

Roche sells off dermatitis drug to Dermira

05:27 EDT 8 Aug 2017 | BioPharmaDive

Lebrikizumab has had disappointing clinical results to date, yet Dermira hopes the IL-13 inhibitor could prove itself in the emerging atopic dermatitis space. 

Original Article: Roche sells off dermatitis drug to Dermira

NEXT ARTICLE

More From BioPortfolio on "Roche sells off dermatitis drug to Dermira"

Quick Search
Advertisement
 

Relevant Topic

Dermatitis
Dermatitis means an inflammation of the skin. Contact dermatitis is a term used when this inflammation is caused by contact with something in the environment. The changes of dermatitis seen in the skin take the form of eczema; hence it may sometimes be r...